Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 11-20 of 58

Page
per page
  1. ZM323881
    A3954 ZM323881
    Target: VEGFR
    Summary: VEGFR-2/KDR inhibitor,potent and selective
      Soluble in DMSO
  2. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  3. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  4. EGF816
    B5889 EGF816
     2 Citation
    Target: EGFR
    Summary: Novel covalent inhibitor of mutant-selective EGFR
      Soluble in DMSO
  5. MLR 1023
    B5648 MLR 1023
    Target: Lyn kinase
    Summary: allosteric activator of Lyn kinase
  6. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL
  7. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor
      ≥25.9 mg/mL
  8. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL
  9. Vatalanib
    A3969 Vatalanib
     1 Citation
    Target: VEGFR
    Summary: VEGFR-1/-2 inhibitor,cell-permeable
      ≥16.85 mg/mL
  10. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL

Items 11-20 of 58

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 2item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 6item
  7. c-RET 1 item
  8. CSF-1R 1 item
  9. EGFR 11item
  10. FAK 3item
  11. FGFR 4item
  12. HER2 5item
  13. LRRK2 4item
  14. PDGFR 6item
  15. Pyk2 2item
  16. Spleen Tyrosine Kinase (Syk) 2item
  17. Src 2item
  18. Tie-2 2item
  19. Trk 1 item
  20. VEGFR 18item
Specificity
  1. Selective 43item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 4item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 24item
  6. PDGFR 7item
  7. c-Kit 5item
  8. RET 2item
  9. Bcr-Abl 1 item
  10. FGFR 7item
  11. MET 4item
  12. Src 1 item
  13. Trk Receptors 2item
  14. EGFR 10item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. Pyk2 3item
  21. LRRK2 4item
  22. Insulin and Insulin-like Receptors 1 item
  23. ALK 1 item
  24. Tie-2 3item
  25. Flk-1 1 item
  26. KDR 1 item
  27. Fyn kinase 1 item
  28. c-Fms tyrosine kinase 1 item
  29. Lyn kinase 1 item
  30. ErbB-2 1 item
  31. DCLK2 1 item
  32. Flk1 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 42item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item